Chronic myeloid leukaemia: a therapeutic challenge.
Mughal
T I
TI
Division of Haematology and Oncology, King Fahad National Guard Hospital, Riyadh, Saudi Arabia.
Goldman
J M
JM
D000970:Antineoplastic Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D016044:Fusion Proteins, bcr-abl / Q000235:genetics; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics / Q000628:therapy*; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
D000970:Antineoplastic Agents; D016376:Oligonucleotides, Antisense; D007372:Interferons; D016044:Fusion Proteins, bcr-abl